Interstitial Lung Disease Trial, Recruiting (NCT05895409)

Interstitial Lung Disease Trial, Recruiting NCT05895409 Sponsor: Qianfoshan Hospital Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05895409 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 80 years old
You are willing to agree to and sign a consent form to take part in the study
You have been diagnosed with an interstitial lung disease (a type of lung condition) that shows signs of scarring in the lungs on imaging scans

Who may not be able to join:

You have been specifically diagnosed with idiopathic pulmonary fibrosis (IPF), which is a particular type of lung scarring disease
You are currently pregnant or breastfeeding
You have a mental health condition or difficulties with memory and thinking that affect your understanding
You are already taking part in another clinical trial or research study
You are unable to sign the consent form for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613853120761

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05895409

Sponsor: Qianfoshan Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Interstitial Lung Disease

Trial contact: +8613853120761

More information: https://clinicaltrials.gov/study/NCT05895409

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 80 years old
You are willing to agree to and sign a consent form to take part in the study
You have been diagnosed with an interstitial lung disease (a type of lung condition) that shows signs of scarring in the lungs on imaging scans

Who may not be able to join:

You have been specifically diagnosed with idiopathic pulmonary fibrosis (IPF), which is a particular type of lung scarring disease
You are currently pregnant or breastfeeding
You have a mental health condition or difficulties with memory and thinking that affect your understanding
You are already taking part in another clinical trial or research study
You are unable to sign the consent form for any reason

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Qianfoshan Hospital

Registry

ClinicalTrials.gov

Start date

27 July 2023

Est. completion

1 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Establish the correlation between Age (years) and progression to PPF; Establish the correlation between Gender (the proportion of female and the proportion of male) and progression to PPF; Establish the correlation between Body mass index (BMI, kg/m2) and progression to PPF; Establish the correlation between ILD-Gender-Age-Physiology score (0-3,4-5 and 6-8) and progression to PPF; Establish the correlation between Artery blood gas and progression to PPF; Establish the correlation between Pulmonary function and progression to PPF; Establish the correlation between 6 min walk test distance (mete...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov